Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Cervical Transcutaneous SCS for TBI

NCT: NCT07147816 · TERMINATED

NCT IDNCT07147816
StatusTERMINATED
Start Date2025-11-26
Completion2026-01-29
SponsorRoberto de Freitas (OTHER)
First posted
Last updated

Brief Summary

The goal of this study is to test the effects of non-invasive electrical stimulation of the spinal cord (called transcutaneous spinal cord stimulation, or tSCS) on arm and hand movement in people with motor impairments after a traumatic brain injury (TBI). Specifically, tSCS will be delivered using adhesive electrode pads placed on the skin over the upper back. The research team will measure how tSCS affects strength, movement control and muscle spasticity using different tests. Results of this study will help develop future treatments using an implanted (invasive) form of spinal cord stimulation to improve arm and hand function, helping people with TBI become more independent and improve their quality of life.

Frequently Asked Questions

What is Cervical Transcutaneous SCS for TBI?

Cervical Transcutaneous SCS for TBI is a clinical trial registered under NCT07147816. Current status: TERMINATED.

What is the status of NCT07147816?

The current status of NCT07147816 (Cervical Transcutaneous SCS for TBI) is: TERMINATED.

When did Cervical Transcutaneous SCS for TBI start?

Cervical Transcutaneous SCS for TBI started on 2025-11-26.

Related Devices

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.